| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
28,787 |
27,010 |
$6.87M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
16,080 |
14,836 |
$5.80M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
33,756 |
32,026 |
$4.47M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
6,174 |
5,874 |
$985K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,174 |
1,118 |
$718K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,975 |
6,026 |
$461K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
8,203 |
2,121 |
$374K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,849 |
12,283 |
$336K |
| 80053 |
Comprehensive metabolic panel |
38,041 |
35,314 |
$326K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
43,925 |
40,640 |
$324K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
1,780 |
1,526 |
$280K |
| 71045 |
Radiologic examination, chest; single view |
5,582 |
5,163 |
$197K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,990 |
3,815 |
$193K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,530 |
2,410 |
$190K |
| 59025 |
Fetal non-stress test |
3,881 |
3,278 |
$189K |
| J3490 |
Unclassified drugs |
95,744 |
48,839 |
$156K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
42,604 |
29,759 |
$148K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
620 |
582 |
$148K |
| 81001 |
|
35,633 |
32,676 |
$119K |
| 36415 |
Collection of venous blood by venipuncture |
51,253 |
45,720 |
$108K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,636 |
3,391 |
$102K |
| 71046 |
Radiologic examination, chest; 2 views |
2,115 |
2,015 |
$95K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
323 |
310 |
$90K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,158 |
1,965 |
$83K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,655 |
1,548 |
$72K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,039 |
2,689 |
$70K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,367 |
1,258 |
$65K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,333 |
1,233 |
$53K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
606 |
508 |
$50K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,184 |
1,113 |
$37K |
| 94760 |
|
2,126 |
1,847 |
$27K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
689 |
660 |
$26K |
| 76801 |
|
387 |
372 |
$24K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,862 |
1,741 |
$24K |
| J2704 |
Injection, propofol, 10 mg |
2,038 |
1,691 |
$22K |
| 84484 |
|
2,822 |
2,174 |
$21K |
| 83690 |
|
2,802 |
2,625 |
$20K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
84 |
65 |
$20K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
991 |
665 |
$19K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,041 |
1,851 |
$19K |
| 88307 |
|
334 |
289 |
$17K |
| 70450 |
Computed tomography, head or brain; without contrast material |
81 |
77 |
$17K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
819 |
484 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,240 |
1,213 |
$15K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
76 |
75 |
$12K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
501 |
132 |
$12K |
| 88304 |
|
605 |
464 |
$12K |
| 30802 |
|
16 |
12 |
$12K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,253 |
1,184 |
$11K |
| 88342 |
|
385 |
315 |
$11K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,187 |
1,103 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
727 |
695 |
$9K |
| 99201 |
|
585 |
402 |
$9K |
| 87070 |
|
787 |
753 |
$8K |
| 93325 |
|
83 |
79 |
$7K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
584 |
531 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
381 |
330 |
$6K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
100 |
40 |
$6K |
| 84703 |
|
549 |
520 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
142 |
129 |
$5K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
52 |
46 |
$5K |
| 81025 |
|
441 |
427 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
105 |
100 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
105 |
100 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
124 |
98 |
$3K |
| 01967 |
Neuraxial labor analgesia/anesthesia for planned vaginal delivery |
32 |
26 |
$3K |
| 93321 |
|
43 |
40 |
$2K |
| 86003 |
|
12 |
12 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
130 |
100 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
213 |
184 |
$2K |
| 82247 |
|
358 |
309 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
103 |
68 |
$2K |
| 99406 |
|
407 |
386 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
277 |
262 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
26 |
25 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
81 |
80 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
42 |
37 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
211 |
175 |
$1K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
58 |
27 |
$1K |
| 93971 |
|
137 |
84 |
$1K |
| 73630 |
|
24 |
24 |
$1K |
| 77073 |
|
13 |
12 |
$1K |
| 00142 |
|
30 |
25 |
$986.27 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
40 |
26 |
$832.37 |
| 82550 |
|
190 |
176 |
$702.47 |
| 81005 |
|
315 |
250 |
$656.18 |
| 73130 |
|
13 |
13 |
$583.30 |
| 80061 |
Lipid panel |
37 |
37 |
$524.10 |
| 84443 |
Thyroid stimulating hormone (TSH) |
24 |
24 |
$487.44 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12 |
12 |
$442.68 |
| 84112 |
|
14 |
13 |
$435.79 |
| V2632 |
Posterior chamber intraocular lens |
56 |
40 |
$429.33 |
| 80076 |
|
34 |
33 |
$329.96 |
| 82785 |
|
12 |
12 |
$321.63 |
| 83735 |
|
39 |
37 |
$300.69 |
| 83655 |
|
17 |
13 |
$268.82 |
| 82553 |
|
39 |
37 |
$262.75 |
| 82248 |
|
358 |
309 |
$235.71 |
| 86140 |
|
32 |
30 |
$223.57 |
| 87420 |
|
16 |
15 |
$214.20 |
| 80047 |
|
19 |
19 |
$189.73 |
| 87210 |
|
43 |
39 |
$145.31 |
| 83605 |
|
15 |
12 |
$140.46 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
13 |
$133.88 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
87 |
68 |
$133.71 |
| 87077 |
|
14 |
12 |
$106.50 |
| 85027 |
|
16 |
13 |
$102.55 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
13 |
12 |
$99.77 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
13 |
12 |
$78.84 |
| 85730 |
|
17 |
12 |
$66.36 |
| 85014 |
|
19 |
19 |
$56.65 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
94 |
91 |
$54.19 |
| 87075 |
|
14 |
12 |
$51.30 |
| 85610 |
|
20 |
15 |
$42.08 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
13 |
12 |
$32.66 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
159 |
156 |
$25.52 |
| 87205 |
|
14 |
12 |
$24.34 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
14 |
12 |
$2.04 |
| 99292 |
|
13 |
13 |
$0.00 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
30 |
29 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
14 |
13 |
$0.00 |